Methods / Design
breast cancer
BREAST CANCER
The WEBAPPAC study is a randomized, open-label, prospective, single-center phase 3 trial aiming to compare the adherence to adjuvant hormone therapy at 18 months between breast cancer patients with the WEBAPPAC web-application support versus standard management. The WEBAPPAC protocol and this manuscript have been written in accordance with standard protocol items, namely recommendations for interventional trials (SPIRIT).